NDC Compounded Drug 69374-319-25 Norepinephrine

Injection, Solution Intravenous

Table of Contents

    1. Compounded Product Information
    2. NDC Crossover Products Matching Norepinephrine Bitartrate 4mg/250ml
    3. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 69374-319
NDC Package Code 69374-319-25
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 69374031925
Package Description 15 CARTON in 1 CASE > 1 BOTTLE, PLASTIC in 1 CARTON > 250 mL in 1 BOTTLE, PLASTIC
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Norepinephrine Bitartrate 4mg/250ml
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Norepinephrine Bitartrate 4mg/250ml
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Norepinephrine
Dosage Form Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Route Name Intravenous - Administration within or into a vein or veins.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 69374
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Nephron Sterile Compounding Center, Llc
Substance Name Norepinephrine
Active Ingredients Information 4 mg/250 mL
Reporting Period 2022-2

NDC Crossover Products Matching Norepinephrine

NDC crossover of Norepinephrine Bitartrate 4mg/250ml with NDC 69374-319 a human compounded drug with other similar products matching the same substance name (Norepinephrine) and the same administration route (intravenous) or dosage form (injection, solution).

Frequently Asked Questions

What is the NDC number assigned to Norepinephrine Bitartrate 8mg Added To 250ml Of 0.9% Sodium Chloride?

Norepinephrine Bitartrate 8mg Added To 250ml Of 0.9% Sodium Chloride was assigned by its manufacturer with NDC product code 69374-319. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Norepinephrine Bitartrate 8mg Added To 250ml Of 0.9% Sodium Chloride?

The NDC package code 69374-319-25 was assigned to a 15 CARTON in 1 CASE > 1 BOTTLE, PLASTIC in 1 CARTON > 250 mL in 1 BOTTLE, PLASTIC of norepinephrine administered intravenous via injection, solution.

Who manufactures this product?

Norepinephrine Bitartrate 8mg Added To 250ml Of 0.9% Sodium Chloride is manufactured by an outsourced facility and labeled by Nephron Sterile Compounding Center, Llc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.

Which are the NDC crossover matchings for this product?

We found 24 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Nephron Sterile Compounding Center, LLC, PROVIDENCE INFUSION HOSPITAL SERVICES, SterRx LLC and Apollo Care, LLC with NDC product codes 69374-315-25, 69374-316-25, 70214-5040-1, 70214-5040-1, 70214-5040-1, 70214-5040-1, 70324-552-01, 70324-552-01, 70324-577-01, 70324-577-01, 70324-602-01, 70324-602-01, 70324-702-01, 70324-702-01, 71170-500-25, 71170-500-25, 71170-500-25, 71170-510-25, 71170-510-25, 71170-520-25, 71170-550-25, 71170-550-25, 71170-550-25 and 71170-550-25.